Name:
Sudip Chaudhuri
|
Position:
Professor
My Home Page
|
Department:
Economics
|
|
Publications
|
BOOK
The WTO and India’s Pharmaceuticals Industry: Patent Protection TRIPS and Developing Countries, New Delhi, Oxford University Press, 2005.
OTHER RECENT RESEARCH AND PROJECTS
(For a list of recent seminar presentations, see below)
“Indian generic producers, access to essential medicines and local production in Africa: an argument with reference to Tanzania”, (jointly with M M Mackintosh and Phares Mujinja), forthcoming in European Journal of Development Research
“Indian Pharmaceutical Industry after TRIPS”, forthcoming, UNDP, New York.
“R&D for Development of new drugs for neglected diseases”, in International Journal of Technology and Globalization, special issue guest edited by Sunil Mani and Sudip Chaudhuri, Vol 5, No 1/2, 2010 .
“Non-Government Intervention and Prices of Medicines in India: Case Studies of CDMU and LOCOST, IKD Working Paper No. 46, February 2009, Open University Research Centre on Innovation Knowledge and Development, Milton Keynes.
“Is Product Patent Protection Necessary to Spur Innovation in Developing Countries? R&D by Indian Pharmaceutical Companies after TRIPS”, in Neil Weinstock Netanel (ed.), The Development Agenda: Global Intellectual Property and Developing Countries, New York, Oxford University Press, 2008
“Indian Generic Companies, Affordability of Drugs and Local Production in Africa withSpecial Reference to Tanzania”, IKD Working Paper No. 37, September 2008, Open University Research Centre on Innovation Knowledge and Development, Milton Keynes.
"Ranbaxy Sell-out: Reversal of Fortunes", Economic and Political Weekly, July 19, 2008.
“Pharmaceutical Industry”, in Kaushik Basu (ed.), The Oxford Companion to Economics in India, New Delhi, Oxford University Press, 2007.
"In-Kind Donations and Access to HIV/AIDS Medicines", Indian Institute of Management Calcutta (mimeo), April, 2007.
“The Gap between Successful Innovation and Access to its Benefits: Indian Pharmaceuticals”, European Journal of Development Research, March 2007.
“Indian Pharmaceutical Companies and Accessibility of Drugs under TRIPS,” in Maureen Mackintosh and Meri Koivusalo (eds.), Commercialization of Health care: Global and Local Dynamics and Policy Response, Houndmills, Palgrave Macmillan, 2005.
“R&D for Development of New Drugs for Neglected Diseases: How can India Contribute.” (A study commissioned by World Health Organization, Commission on Intellectual Property Rights Innovation and Public Health, Geneva, March, 2005).
“Generic Competition, Price Control and Affordability of Drugs in India”, Working Paper No 478, Indian Institute of Management Calcutta, September, 2003.
“The TRIPS Agreement and the Amendment of the Patents Act in India”, Economic and Political Weekly, August 10, 2002.
“Compulsory Licensing under India’s Amended Patent Act”, Technology Policy Brief, Vol 1, No 3, 2002, Institute for New Technologies, United Nations University, Maastricht.
“Economic Reforms and Industrial Structure in India”, Economic and Political Weekly, January 12, 2002
RECENT PRESENTATIONS IN CONFERENCES/SEMINARS/WORKSHOPS AS AN INVITED SPEAKER
“India-Brazil-South Africa (IBSA) Academic Forum: A Policy Dialogue”, 12-13 April, 2010, Brasilia, Brazil.
“Asian Dialogue for Technology Transfer for Local Manufacturing of Drugs and vaccines”, Kuala Lumpur, 29-30 April, 2010
“Tracing Pharmaceuticals in South Asia: Dissemination Workshop”, Edinburgh, June 17-19, 2009
“Workshop on Alternate Patent Regime and Access to Health”, RIS and CASTED, May 25-26, 2009, Beijing, China
"Pharmaceutical Innovation in India after TRIPS: Status and Implications", Panel on Innovation and Patents in India organized by CESMEO, International Institute for Advanced Asian Studies, Turin, November 18, 2008
"Affordability of Drugs and Local Production: Tanzania and India", WHO Advanced Technical Briefing Seminar on Medicine Prices, Availability and Price Regulation,
New Delhi, 10-14 November, 2008,
"Affordability of Drugs and Local Production: Is there a Common Interest between Tanzania and India?", Workshop on Are there common interests? Exploring Common and Conflicting Interests in Public Action between North and South, London, November 4, 2008
“Global Strategies of Indian Pharmaceutical Companies, Pharmaceutical Prices and Industry in Africa with Special Reference To Tanzania”, Access to Medicines Workshop
Bagamoyo, Tanzania, June 7, 2008
"Pharmaceutical Prices and India", Conference on Pharmaceutical Pricing and Regulatory Framework for Affordable Prices, NPPA in collaboration with DFID, New Delhi, April 12, 2008
"Is Product Patent Protection Necessary in Developing Countries for Innovation? R&D by Indian Pharmaceutical Companies after TRIPS", ICTSD/UNCTAD Roundtable Geneva, October 11, 2007
"India's Pharmaceutical Industry After TRIPS" at the conference in memory of Jenny Lanjouw at the University of California, Berkeley, March 30-31, 2007.
"Is More IP Good for Developing Countries?: The Case of India's Pharmaceutical Industry", UCLA School of Law Conference on the Development Agenda, Los Angeles, March 11-12, 2007
“Pharmaceuticals before and after TRIPS”, Globelics (The Global Network for the Economics of Learning, Innovation, and Competence Building Systems) “BRICS Workshop”, Aalborg, Denmark, 12-15 February, 2006
“TRIPS, Indian Generic Companies and Affordability of Drugs”, Conference on “Living with TRIPS: Innovation of New Health Technologies for the Poor”, MIHR (Centre for Management of Intellectual Property in Health Research and Development and ICMR (Indian Council of Medical Research), New Delhi, 4-7 December, 2005
“Incentives for Fostering Pharmaceutical R&D: The Case of India”, Conference on “Bridging the Gulf between Policies for Innovation, Productivity & Industrial Growth & Policies to Reduce Poverty”, The Institute of Commonwealth Studies, London, 18-20 November 2005
“Product patent Protection and Industrial Development: What do we learn from India’s Pharmaceutical Industry?”, “Conference on New Approaches to Intellectual Property”, Columbia university, New York, June 13-14, 2005
“Product Patent Protection and Exports of Affordable Generic Medicines from India”, Conference on “Realizing the Right to Health: A Global South Dialogue on HIV/AIDS & Access to Treatment”, Lawyers Collective HIV/AIDS Unit, Mumbai, India, 18-21 March 2005
“TRIPS, Indian Generic Companies and Accessibility of Medicines”, “Conference on Global Pharmaceuticals, Biotechnology and Health, Institute for Strategic Biotechnology, Health and Training, Mumbai, 6 August, 2004
“Response of Indian Companies to TRIPS and Accessibility of Medicines”, “UNRISD International Conference on Commercialization of Health Care: Global and Local Dynamics and Policy Responses”, Helsinki, 15–17 March 2004
“Will TRIPS Increase R&D in Drugs for Neglected Diseases?: Lessons from India’s experience”, “MSF Neglected Diseases Group Meeting”, Penang, Malaysia , 6-7 February, 2004,
“Options Under TRIPS Agreement and Accessibility of Medicines after 2005”, “Third Meeting of MSF IPR Working Group”, Penang, Malaysia , 5 February, 2004
“Impact of Global and National Regulatory Changes on Affordability and Accessibility of Drugs in India”, UNRISD Workshop, March 3-5, 2003, Geneva.
“WTO, Trade Agreements and Pharmaceutical Policies in Developing Countries”, “GASPP Policy Briefs on Global Governance Seminar”, Helsinki, 23 January, 2003
“TRIPS and Patent Law in India”, Conference on “Medical Patents: Global Ethical and Economic Perspectives for Developing Countries”, organised by The North/South Priority Research Area of the University of Copenhagen at Copenhagen, May 6, 2002.
|
|
Research Interests
|
|
Industrialisation and economic development in developing countries, India's industrial development, the role of state in economic change, globalisation and liberalisation in developing countries, WTO, TRIPS, patents, pharmaceutical industry and health.
|
|
|
